How do environmental agents affect inflammatory skin disease?

References

• Burden of Skin Disease report. Available from the Society for Investigative Dermatology. OH , USA (2005).
   Google Scholar
• Kimber I, Dearman RJ. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis.46(1), 1–5 (2002).
   PubMed Web of Science ®Google Scholar
• Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin. Exp. Dermatol.27(2), 138–146 (2002).
   PubMed Web of Science ®Google Scholar
• Kripke ML, Morison WL. Modulation of immune function by UV radiation. J. Invest. Dermatol.85(1 Suppl.), S62–S66 (1985).
   Google Scholar
• Sabra A, Bellanti JA, Rais JM, Castro HJ, de Inocencio JM, Sabra S. IgE and non-IgE food allergy. Ann. Allergy Asthma Immunol.90(6 Suppl. 3), 71–76 (2003).
   PubMed Web of Science ®Google Scholar
• Van Hoogstraten IM, Andersen KE, Von Blomberg BM et al. Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin. Exp. Immunol.85(3), 441–445 (1991).
   PubMed Web of Science ®Google Scholar
• Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J. Immunol.171(11), 5760–5768 (2003).
   PubMed Web of Science ®Google Scholar
• Bruijnzeel-Koomen CA, Mudde GC, Bruijnzeel PL. The presence of IgE molecules on epidermal Langerhans cells in atopic dermatitis and their significance for its pathogenesis. Allerg. Immunol. (Paris)21(6), 219–223 (1989).
   PubMedGoogle Scholar
• Meglio P, Arabito E, Plantamura M, Businco L. Prevalence of latex allergy and evaluation of some risk factors in a population of atopic children. J. Invest. Aller. Clin. Immunol.12(4), 250–256 (2002).
   PubMed Web of Science ®Google Scholar
• Lintu P, Savolainen J, Kortekangas-Savolainen O, Kalimo K. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy56(6), 512–517 (2001).
   PubMed Web of Science ®Google Scholar
• Bayrou O, Pecquet C, Flahault A, Artigou C, Abuaf N, Leynadier F. Head and neck atopic dermatitis and malassezia-furfur-specific IgE antibodies. Dermatology211(2), 107–113 (2005).
   PubMed Web of Science ®Google Scholar
• Hall RP 3rd, Smith AD, Streilein RD. Increased production of IL-4 by gut T-cell lines from patients with dermatitisherpetiformis compared to patients with isolated gluten-sensitive enteropathy. Dig. Dis. Sci.45(10), 2036–2043 (2000).
   PubMed Web of Science ®Google Scholar
• Elias PM. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol.125(2), 183–200 (2005).
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med.347(15), 1151–1160 (2002).
   PubMed Web of Science ®Google Scholar
• Clark R, Kupper T. Old meets new: the interaction between innate and adaptive immunity. J. Invest. Dermatol.125(4), 629–637 (2005).
   PubMed Web of Science ®Google Scholar
• Kissenpfennig A, Henri S, Dubois B et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity22(5), 643–654 (2005).
   PubMed Web of Science ®Google Scholar
• Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity23(6), 611–620 (2005).
   PubMed Web of Science ®Google Scholar
• Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Aller. Clin. Immunol.113(4), 756–763 (2004).
   PubMed Web of Science ®Google Scholar
• Sugiyama H, Gyulai R, Toichi E et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol.174(1), 164–173 (2005).
   PubMed Web of Science ®Google Scholar
• Verhagen J, Akdis M, Traidl-Hoffmann C et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J. Aller. Clin. Immunol.117(1), 176–183 (2006).
   PubMed Web of Science ®Google Scholar
• Esche C, Stellato C, Beck LA. Chemokines: key players in innate and adaptive immunity. J. Invest. Dermatol.125(4), 615–628 (2005).
   PubMed Web of Science ®Google Scholar
• Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J. Aller. Clin. Immunol.97(5), 1064–1070 (1996).
   PubMed Web of Science ®Google Scholar
• Mallbris L, Edstrom DW, Sundblad L, Granath F, Stahle M. UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J. Invest. Dermatol.125(5), 1072–1074 (2005).
   PubMed Web of Science ®Google Scholar
• Zasloff M. Sunlight, vitamin D, and the innate immune defenses of the human skin. J. Invest. Dermatol.125(5), xvi–xvii (2005).
   PubMedGoogle Scholar
• Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol.80(5), 477–483 (2002).
   PubMed Web of Science ®Google Scholar
• Mudde GC, Van Reijsen FC, Boland GJ, de Gast GC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Allergen presentation by epidermal Langerhans’ cells from patients with atopic dermatitis is mediated by IgE. Immunology69(3), 335–341 (1990).
   PubMed Web of Science ®Google Scholar
• Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today19(8), 359–361 (1998).
   PubMedGoogle Scholar
• Simpson EL, Hanifin JM. Atopic dermatitis. J. Am. Acad. Dermatol.53(1), 115–128 (2005).
   PubMed Web of Science ®Google Scholar
• Gaspari AA, Burns R, Nasir A, Ramirez D, Barth RK, Haidaris CG. CD86 (B7–2), but not CD80 (B7–1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections. Infect. Immunol.66(9), 4440–4449 (1998).
   PubMed Web of Science ®Google Scholar
• Burns R, Luzina I, Nasir A, Haidaris CG, Barth RK, Gaspari AA. Keratinocyte-derived, CD80-mediated costimulation is associated with hapten-specific IgE production during contact hypersensitivity to TH1 haptens. J. Aller. Clin. Immunol.115(2), 383–390 (2005).
   PubMed Web of Science ®Google Scholar
• Pivarcsi A, Gombert M, Dieu-Nosjean MC et al. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J. Immunol.173(9), 5810–5817 (2004).
   Google Scholar
• Bos JD, de Rie MA, Teunissen MB, Piskin G. Psoriasis: dysregulation of innate immunity. Br. J. Dermatol.152(6), 1098–1107 (2005).
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J. Am. Acad. Dermatol.49(6), 1088–1095 (2003).
   PubMedGoogle Scholar
• Lehto M, Haapakoski R, Wolff H et al. Cutaneous, but not airway, latex exposure induces allergic lung inflammation and airway hyperreactivity in mice. J. Invest. Dermatol.125(5), 962–968 (2005).
   PubMed Web of Science ®Google Scholar
• Kramer U, Weidinger S, Darsow U, Mohrenschlager M, Ring J, Behrendt H. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J. Invest. Dermatol.124(3), 514–523 (2005).
   PubMed Web of Science ®Google Scholar
• Darsow U, Vieluf D, Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J. Am. Acad. Dermatol.40(2 Pt 1), 187–193 (1999).
   PubMed Web of Science ®Google Scholar
• Janssens V, Morren M, Dooms-Goossens A, Degreef H. Protein contact dermatitis: myth or reality? Br. J. Dermatol.132(1), 1–6 (1995).
   PubMed Web of Science ®Google Scholar
• Guin JD. Clinical presentations of patients sensitive to natural rubber latex. Dermatitis15(4), 192–196 (2004).
   PubMedGoogle Scholar
• Adam E, Hansen KK, Astudillo OF et al. The house dust mite allergen DER P 1, unlike DER P 3, stimulates the expression of IL-8 in human airway epithelial cells via a proteinase-activated receptor -2 (PAR2) independent mechanism. J. Biol. Chem.281(11), 6910–6923 (2005).
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci.23(15), 6176–6180 (2003).
   PubMed Web of Science ®Google Scholar
• Johansson C, Tengvall Linder M, Aalberse RC, Scheynius A. Elevated levels of IgG and IgG4 to Malassezia allergens in atopic eczema patients with IgE reactivity to Malassezia. Int. Arch. Aller. Immunol.135(2), 93–100 (2004).
   PubMed Web of Science ®Google Scholar
• Hewitt M, Barrow GI, Miller DC, Turk F, Turk S. Mites in the personal environment and their role in skin disorders. Br. J. Dermatol.89(4), 401–409 (1973).
   PubMed Web of Science ®Google Scholar
• Ramirez De Knott HM, McCormick TS et al. Cutaneous hypersensitivity to Malassezia sympodialis and dust mite in adult atopic dermatitis with a textile pattern. Contact Derm.54(2), 92–99 (2006).
   PubMed Web of Science ®Google Scholar
• Ramirez De Knott HM, McCormick TS, Do SO et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Derm.53(4), 214–218 (2005).
   PubMed Web of Science ®Google Scholar
• Tang N, Liu L, Kang K et al. Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase. Infect. Immunol.72(5), 2513–2520 (2004).
   PubMed Web of Science ®Google Scholar
• Montagnoli C, Fallarino F, Gaziano R et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol.176(3), 1712–1723 (2006).
   PubMed Web of Science ®Google Scholar
• Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br. J. Dermatol.148(5), 1021–1027 (2003).
   PubMed Web of Science ®Google Scholar
• Foster DC, Dworkin RH, Wood RW. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. Pain117(1–2), 128–136 (2005).
   PubMed Web of Science ®Google Scholar
• Vieths S, Scheurer S, Ballmer-Weber B. Current understanding of cross-reactivity of food allergens and pollen. Ann. NY Acad. Sci.964, 47–68 (2002).
   PubMed Web of Science ®Google Scholar
• Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J. Aller. Clin. Immunol.104(2 Pt 1), 466–472 (1999).
   PubMed Web of Science ®Google Scholar
• Chang YC, George SJ, Hsu S. Oral allergy syndrome and contact urticaria to apples. J. Am. Acad. Dermatol.53, 736–737 (2005).
   PubMed Web of Science ®Google Scholar
• Werfel T, Reekers R, Busche M et al. Association of birch pollen-related food-responsive atopic dermatitis with birch pollen allergen-specific T-cell reactions. Curr. Prob. Dermatol.28, 18–28 (1999).
   PubMedGoogle Scholar
• Sigmundsdottir H, Johnston A, Gudjonsson JE, Bjarnason B, Valdimarsson H. Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin. Expert Dermatol.13(7), 426–434 (2004).
   PubMed Web of Science ®Google Scholar
• Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J. Am. Acad. Dermatol.40(4), 612–614 (1999).
   PubMed Web of Science ®Google Scholar
• Salam TN, Fowler JF Jr. Balsam-related systemic contact dermatitis. J. Am. Acad. Dermatol.45(3), 377–381 (2001).
   PubMed Web of Science ®Google Scholar
• Kaaber K, Menne T, Tjell JC, Veien N. Antabuse treatment of nickel dermatitis. Chelation – a new principle in the treatment of nickel dermatitis. Contact Derm.5(4), 221–228 (1979).
   PubMed Web of Science ®Google Scholar
• Peck S. Epidermophytosis of the feet and epidermophytids of the hands: clinical, histologic,cultural, and experimental studies. Arch. Dermatol. Syph.20, 44–76 (1930).
   Google Scholar
• Turjanmaa K. The role of atopy patch tests in the diagnosis of allergy in atopic dermatitis. Curr. Opin. Aller. Clin. Immunol.5(5), 425–428 (2005).
   PubMed Web of Science ®Google Scholar
• Flint MS, Depree KM, Rich BA, Tinkle SS. Differential regulation of sensitizer-induced inflammation and immunity by acute restraint stress in allergic contact dermatitis. J. Neuroimmunol.140(1–2), 28–40 (2003).
   PubMed Web of Science ®Google Scholar
• Nakano Y. Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress. Br. J. Dermatol.151(1), 50–64 (2004).
   PubMedGoogle Scholar
• Dhabhar FS, Viswanathan K. Short-term stress experienced at time of immunization induces a long-lasting increase in immunologic memory. Am. J. Physiol. Regul. Integr. Comp. Physiol.289(3), R738–R744 (2005).
   Web of Science ®Google Scholar
• Fidel PL Jr. Immunity in vaginal candidiasis. Curr. Opin. Infect. Dis.18(2), 107–111 (2005).
   PubMedGoogle Scholar
• Fidel PL Jr. Host defense against mucosal candidiasis: anatomical distinctions and paradigm chenges. Skin Disease Reasearch Center lecture. University Hospitals of Cleveland/Case Western Reserve University (2005).
   Google Scholar
• Eedy DJ, Shaw C, Johnston CF, Buchanan KD. The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin. Exp. Dermatol.19(6), 463–472 (1994).
   PubMed Web of Science ®Google Scholar
• Swartling C, Naver H, Lindberg M, Anveden I. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J. Am. Acad. Dermatol.47(5), 667–671 (2002).
   PubMed Web of Science ®Google Scholar
• Klein AW. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J. Am. Acad. Dermatol.50(1), 153–154 (2004).
   PubMed Web of Science ®Google Scholar
• Kramer HH, Angerer C, Erbguth F, Schmelz M, Birklein F. Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J. Neurol.250(2), 188–193 (2003).
   PubMed Web of Science ®Google Scholar
• Gunter J, Brewer A, Tawfik O. Botulinum toxin A for vulvodynia: a case report. J. Pain5(4), 238–240 (2004).
   PubMed Web of Science ®Google Scholar
• Niizeki H, Kurimoto I, Streilein JW. A substance P agonist acts as an adjuvant to promote hapten-specific skin immunity. J. Invest. Dermatol.112, 437–442 (1999).
   PubMed Web of Science ®Google Scholar
• Seiffert K, Hosoi J, Torii H et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J. Immunol.168(12), 6128–6135 (2002).
   PubMed Web of Science ®Google Scholar
• Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J. Immunol.154, 3056–3061 (1995).
   PubMed Web of Science ®Google Scholar
• Kodali S, Friedman I, Ding W et al. Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function. Eur. J. Immunol.33, 3070–3079 (2003).
   PubMed Web of Science ®Google Scholar
• Kodali S, Ding W, Huang J, Seiffert K, Wagner JA, Granstein RD. Vasoactive intestinal peptide modulates Langerhans cell immune function. J. Immunol.173(10), 6082–6088 (2004).
   PubMed Web of Science ®Google Scholar
• Luger TA, Brzoska T, Scholzen TE et al. The role of α-MSH as a modulator of cutaneous inflammation. Ann. NY. Acad. Sci.917, 232–238 (2000).
   PubMed Web of Science ®Google Scholar
• Babu RJ, Kikwai L, Jaiani LT et al. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. Pharm. Res.21(1), 108–113 (2004).
   PubMed Web of Science ®Google Scholar
• Scholzen TE, Steinhoff M, Bonaccorsi P et al. Neutral endodpeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J. Immunol.166, 1285–1291 (2001).
   PubMed Web of Science ®Google Scholar
• Bae S, Lee J, Takenaka M, Tanaka Y, Shimizu K, Katayama I. Topical glucocorticoid augments scratching behaviour in dinitrofluorobenzene-sensitized mice by the induction of substance P. Exp. Dermatol.13(12), 780–785 (2004).
   PubMed Web of Science ®Google Scholar
• Scholzen TE, Ständer S, Riemann H et al. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J. Immunol.170, 3866–3873 (2003).
   PubMed Web of Science ®Google Scholar
• Maestroni G. Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and T helper priming. J. Invest. Dermatol.122, 119–124 (2004).
   PubMed Web of Science ®Google Scholar
• Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J. Intern. Med.257(2), 156–166 (2005).
   PubMed Web of Science ®Google Scholar
• Saripalli YV, Achen F, Belsito DV. The detection of clinically relevant contact allergens using a standard screening tray of twenty-three allergens. J. Am. Acad. Dermatol.49(1), 65–69 (2003).
   PubMed Web of Science ®Google Scholar
• Hoeck UL. More T.R.U.E Test allergens are needed. J. Am. Acad. Dermatol.52(3 Pt 1), 538 (2005).
   PubMedGoogle Scholar
• Veremis-Ley M, Ramirez H, Baron E et al. Laser assisted penetration of allergens for patch testing. Dermatitis (2006) (In Press).
   Google Scholar
• Ulevitch RJ. Therapeutics targeting the innate immune system. Nat. Rev. Immunol.4(7), 512–520 (2004).
   PubMed Web of Science ®Google Scholar
• Zhu D, Kepley CL, Zhang K, Terada T, Yamada T, Saxon A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat. Med.11(4), 446–449 (2005).
   PubMed Web of Science ®Google Scholar
• Kinet JP. A new strategy to counter allergy. N. Engl. J. Med.353(3), 310–312 (2005).
   PubMed Web of Science ®Google Scholar
• Ellis CN, Krueger GG (Alefacept Clinical Study Group). Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N. Engl. J. Med.345(4), 248–255 (2001).
   PubMed Web of Science ®Google Scholar
• Partidos CD, Muller S. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy. Cell Mol. Life Sci.62(13), 1418–1424 (2005).
   PubMed Web of Science ®Google Scholar
• Lu Z, Ghazizadeh S. Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes. Exp. Dermatol.14(10), 727–735 (2005).
   PubMed Web of Science ®Google Scholar
• Takashima A. Dendritic cell engineering in basic and applied immunology. Skin Diseases Research Center lecture. University Hospitals of Cleveland/Case Western Reserve University (2005).
   Google Scholar
• Verhagen J, Taylor A, Akdis M, Akdis CA. Targets in allergy-directed immunotherapy. Expert Opin. Ther. Targets.9(2), 217–224 (2005).
   PubMed Web of Science ®Google Scholar
• Isomura I, Tsujimura K, Morita A. Antigen-specific peripheral tolerance induced by topical application of NF-κB decoy oligodeoxynucleotide. J. Invest. Dermatol.126(1), 97–104 (2006).
   PubMedGoogle Scholar
• Xia J, Song X, Bi Z, Chu W, Wan Y. UV-induced NF-κB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. Int. J. Mol. Med.16(5), 943–950 (2005).
   PubMed Web of Science ®Google Scholar
• Bohm M, Wolff I, Scholzen TE et al. α-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem.280(7), 5795–5802 (2005).
   PubMed Web of Science ®Google Scholar